Genmab A/S (VIE:GMAB)
Austria · Delayed Price · Currency is EUR 271.30
+0.10 (0.04%)
At close: Dec 3, 2025
Genmab Market Cap
Genmab has a market cap or net worth of €17 billion as of December 5, 2025. Its market cap has increased by 36.45% in one year.
Market Cap
17.00B
Enterprise Value
14.21B
Revenue
3.28B
Ranking
n/a
PE Ratio
12.60
Stock Price
€271.30
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 485.53M to 17.00B, an increase of 3,401.29%. That is a compound annual growth rate of 15.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 17.00B | 33.68% |
| Dec 30, 2024 | 12.72B | -32.67% |
| Dec 29, 2023 | 18.89B | -26.92% |
| Dec 30, 2022 | 25.84B | 11.67% |
| Dec 30, 2021 | 23.14B | 6.90% |
| Dec 30, 2020 | 21.65B | 67.74% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erste Group Bank AG | 37.86B |
| VERBUND AG | 22.15B |
| OMV Aktiengesellschaft | 15.70B |
| Raiffeisen Bank International AG | 11.72B |
| Strabag SE | 9.10B |
| BAWAG Group AG | 9.05B |
| Voestalpine AG | 6.43B |
| Vienna Insurance Group AG | 6.23B |